Abstract
As part of a multi-year project that monitored illness-related school closures, we conducted systematic daily online searches from July 27, 2020–June 30, 2022, to identify public announcements of COVID-19-related school closures (COVID-SCs) in the US lasting ≥1 day. We explored the temporospatial patterns of COVID-SCs and analyzed associations between COVID-SCs and national COVID-19 surveillance data. COVID-SCs reflected national surveillance data: correlation was highest between COVID-SCs and both new PCR test positivity (correlation coefficient, r = 0·73, CI: 0·56, 0·84) and new cases (r = 0·72, CI: 0·54, 0·83) in school year (SY) 2020-21, and with hospitalization rates among all ages (rs = 0·81, CI: [0·67, 0·89]) in SY 2021-22. The number of reactive COVID-SCs during SYs 2020-21 and 2021-22 greatly exceeded previously observed numbers of illness-related reactive school closures in the US, notably being nearly 5-fold greater than reactive closures observed during the 2009 H1N1 Pandemic (H1N1pdm09 virus).
Article summary line COVID-19-related school closures occurred annually in the US and their temporal patterns mirror the general patterns of COVID-19 activity at the national level as observed through routine COVID-19 epidemiological surveillance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the US Centers for Disease Control and Prevention (CDC). The co-authors are or were employees of the CDC (NZ FA AU), contractors (FJ) of the US CDC, or ORISE Fellows (SM) at the time of the study. Ferdous Jahan (FJ) is employed by Cherokee Nation Operational Solutions, LLC. The funder (Cherokee Nation Operational Solutions, LLC) provided support in the form of salary for the author (FJ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. During the study period, SM was a fellow appointed through the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the US Centers for Disease Control and Prevention.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵2 Current affiliate: Henry M. Jackson Foundation, Bethesda, Maryland, USA.
Data Availability
All data produced in the present study will be made available upon acceptance by a peer review journal.
